The expression of IL-22 and IL-22R1 was significantly related to lymph node metastasis (P = .002, P = .009) and clinical stage of LSCC (P = .001, P = .037). The gene discussed is IL22; the disease is metastatic malignant neoplasm in the lymph nodes.